Sphera Funds Management Ltd. Kezar Life Sciences, Inc. Transaction History

Sphera Funds Management Ltd.

$545 Million
Q3 2024

A detailed history of Sphera Funds Management Ltd. transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 205,168 shares of KZR stock, worth $1.34 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

205,168

Previous 2,051,676 90.0%

Holding current value

$1.34 Million

Previous $1.23 Million 87.25%

% of portfolio

0.03%

Previous 0.18%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.53 - $0.77 $978,649 - $1.42 Million	-1,846,508 Reduced 90.0%	205,168 $157,000
Q3 2023 Nov 14, 2023	BUY	$1.08 - $2.54 $68,523 - $161,157	63,448 Added 3.19%	2,051,676 $2.44 Million
Q2 2023 Aug 14, 2023	BUY	$2.31 - $3.06 $231,000 - $306,000	100,000 Added 5.3%	1,988,228 $4.87 Million
Q1 2023 May 15, 2023	BUY	$3.13 - $7.31 $1.82 Million - $4.26 Million	583,045 Added 44.67%	1,888,228 $5.91 Million
Q4 2022 Feb 14, 2023	BUY	$6.39 - $8.8 $379,419 - $522,517	59,377 Added 4.77%	1,305,183 $9.19 Million
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $7.56 Million - $10.2 Million	946,152 Added 315.75%	1,245,806 $10.7 Million
Q2 2022 Aug 15, 2022	BUY	$4.58 - $17.13 $513,211 - $1.92 Million	112,055 Added 59.73%	299,654 $2.48 Million
Q1 2022 May 16, 2022	SELL	$12.3 - $18.33 $1.84 Million - $2.74 Million	-149,694 Reduced 44.38%	187,599 $3.12 Million
Q4 2021 Feb 14, 2022	BUY	$7.44 - $16.72 $2.51 Million - $5.64 Million	337,293 New	337,293 $5.64 Million
Q3 2019 Nov 14, 2019	SELL	$3.0 - $7.58 $207,600 - $524,536	-69,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$7.09 - $21.9 $490,628 - $1.52 Million	69,200 New	69,200 $0
Q1 2019 May 15, 2019	SELL	$16.83 - $23.75 $336,599 - $475,000	-20,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$20.21 - $32.9 $3.88 Million - $6.32 Million	-192,000 Reduced 90.57%	20,000 $472,000
Q3 2018 Nov 14, 2018	SELL	$15.5 - $21.41 $246,450 - $340,419	-15,900 Reduced 6.98%	212,000 $4.54 Million
Q2 2018 Aug 13, 2018	BUY	$17.15 - $17.79 $3.91 Million - $4.05 Million	227,900 New	227,900 $3.94 Million

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Kezar Life Sciences, Inc. Transaction History